Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 15, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Robyn Karnauskas Reiterated (BMRN) at Strong Buy and Held Target at $140 on, Sep 15th, 2023
Robyn Karnauskas of Truist Securities, Reiterated "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy and Held Target at $140 on, Sep 15th, 2023.
Robyn has made no other calls on BMRN in the last 4 months.
There are 13 other peers that have a rating on BMRN. Out of the 13 peers that are also analyzing BMRN, 5 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Wednesday, September 13th, 2023
- Andreas Argyrides of "Wedbush" Maintained at Hold with Decreased Target to $70 on, Tuesday, August 1st, 2023
- George Farmer of "Scotiabank" Initiated at Hold and Held Target at $95 on, Thursday, July 27th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Decreased Target to $104 on, Monday, July 3rd, 2023
- David Lebowitz of "Citigroup" Maintained at Hold with Decreased Target to $96 on, Friday, June 30th, 2023
These are the ratings of the 8 analyists that currently disagree with Robyn
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $120 on, Thursday, September 14th, 2023
- Debjit Chattopadhyay of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Wednesday, September 13th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $125 on, Tuesday, August 1st, 2023
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, August 1st, 2023
- Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $185 on, Friday, July 21st, 2023
- Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Held Target at $102 on, Wednesday, July 5th, 2023
- Joel Beatty of "Baird" Reiterated at Buy and Held Target at $127 on, Friday, June 30th, 2023
- Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $120 on, Wednesday, June 14th, 2023
